Please provide your email address to receive an email when new articles are posted on . RXi announced the closing of a global license agreement for the therapeutic use of Samcyprone topical gel with ...
MEMPHIS, Tenn., Nov. 19, 2015 /PRNewswire/ -- Hapten Sciences, Inc., a privately held biotechnology company, announced today that it has filed an Investigational New Drug (IND) application and is now ...
The prognosis valve of tumor regression grade in the same ypStage patients after neoadjuvant treatment in locally advanced rectal cancer: Post-hoc analysis of a prospective trial. This is an ASCO ...
Non-invasive imaging of gene expression is important for both current and future clinical gene therapy trials, allowing definition of the location, magnitude and persistence of gene expression.
Hapten Sciences and Particle Sciences are working together to move Hapten’s poison ivy, oak, and sumac therapy into clinical trials. According to Memphis-based Hapten, its injectable small-molecule ...
Economic analysis of adjuvant interferon alfa-2b in high-risk melanoma based on projections from Eastern Cooperative Oncology Group 1684. Of 62 patients with metastasis in a single lymph node bed ...
Specific IgG antibodies directed against the spin-label nitroxide group present as a lipid hapten in single-compartment lipid vesicles have been visualized by using freeze-etch electron microscopy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results